TOI vs. XLV
TOI (The Oncology Institute, Inc.) is a stock, while XLV (State Street Health Care Select Sector SPDR ETF) is Health & Biotech Equities fund tracking the Health Care Select Sector Index. Over the past 3 years, TOI returned 107.87%/yr vs 6.63%/yr for XLV. At a 0.08 correlation, their price movements are largely independent.
Performance
TOI vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TOI achieves a 41.29% return, which is significantly higher than XLV's -0.85% return.
TOI
- 1D
- 0.40%
- 1M
- 9.59%
- YTD
- 41.29%
- 6M
- 48.82%
- 1Y
- 119.65%
- 3Y*
- 107.87%
- 5Y*
- —
- 10Y*
- —
XLV
- 1D
- 1.41%
- 1M
- 1.98%
- YTD
- -0.85%
- 6M
- -0.97%
- 1Y
- 17.16%
- 3Y*
- 6.63%
- 5Y*
- 5.69%
- 10Y*
- 10.01%
TOI vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TOI The Oncology Institute, Inc. | 41.29% | 1,052.10% | -84.85% | 23.64% | -83.08% | -4.60% |
XLV State Street Health Care Select Sector SPDR ETF | -0.85% | 14.50% | 2.47% | 2.07% | -2.08% | 5.70% |
Correlation
The correlation between TOI and XLV is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Nov 15, 2021 | 0.08 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TOI vs. XLV — Risk / Return Rank
TOI
XLV
TOI vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Oncology Institute, Inc. (TOI) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TOI | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.35 | ||
| Sortino ratioReturn per unit of downside risk | +0.52 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.20 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 2.42 | 1.65 | +0.77 |
| Martin ratioReturn relative to average drawdown | 4.86 | 3.89 | +0.98 |
Loading charts...
Drawdowns
TOI vs. XLV - Drawdown Comparison
The maximum TOI drawdown since its inception was -98.79%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for TOI and XLV.
Loading charts...
Drawdown Indicators
| TOI | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.79% | -39.17% | -59.62% |
Max Drawdown (1Y)Largest decline over 1 year | -49.79% | -10.47% | -39.32% |
Max Drawdown (3Y)Largest decline over 3 years | -94.82% | -17.11% | -77.71% |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.11% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.40% | — |
Current DrawdownCurrent decline from peak | -53.90% | -4.20% | -49.70% |
Average DrawdownAverage peak-to-trough decline | -73.98% | -7.12% | -66.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.70% | 4.42% | +20.28% |
Volatility
TOI vs. XLV - Volatility Comparison
The Oncology Institute, Inc. (TOI) has a higher volatility of 21.02% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 5.27%. This indicates that TOI's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TOI | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.02% | 5.27% | +15.75% |
Volatility (6M)Calculated over the trailing 6-month period | 50.61% | 10.68% | +39.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.82% | 15.09% | +65.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.02% | 14.77% | +98.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.02% | 16.57% | +96.45% |
Dividends
TOI vs. XLV - Dividend Comparison
TOI has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.66%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TOI The Oncology Institute, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV State Street Health Care Select Sector SPDR ETF | 1.66% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
TOI and XLV have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TOI has higher volatility (21.02%) compared to XLV (5.27%). In terms of maximum drawdown, TOI dropped -98.79% vs XLV's -39.17%.
TOI currently has the higher Sharpe Ratio (1.49 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TOI and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer